Dr. Reddy's Files FDA ANDA For UCB Epilepsy Drug

Law360, New York (March 22, 2004, 12:00 AM EST) -- Indian drug maker Dr. Reddy's Laboratories has filed an abbreviated new drug application with the United States Food and Drug Administration for levetiracetam, a generic form of Belgian pharmaceutical company UCB's epilepsy drug Keppra.

UCB has already filed a law suit against Dr.Reddy's in the U.S. district court for the District of Georgia, alleging patent infringement on the two Orange Book patents.

Dr. Reddy’s said it had made a Paragraph IV filing on the two patents in the so-called "Orange Book", which lists multiple patents on...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.